Clinical Trial: A Long-term Safety and Efficacy Study Evaluating CM512 in Atopic Dermatitis.

U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07230483) titled 'A Long-term Safety and Efficacy Study Evaluating CM512 in Atopic Dermatitis.' on Nov. 13.

Brief Summary: This is an Open-label ,Multicenter Study to evaluate Long-Term Safety and Efficacy of CM512 in patients with Atopic Dermatitis who have completed treatment in parent CM512 Study.

Study Start Date: Dec., 2025

Study Type: INTERVENTIONAL

Condition: Atopic Dermatitis (AD)

Intervention: BIOLOGICAL: CM512

CM512 subcutaneous injection

Recruitment Status: RECRUITING

Sponsor: Keymed Biosciences Co.Ltd

Disclaimer: Curated by HT Syndication....